Treatment of stage I seminoma: Should beta-HCG positive seminoma be treated aggressively?

International Urology and Nephrology

Volumn 30, Issue 5, 1998, Pages 593-598

  Suzuki, K ^a,a   Nakazato, H ^a   Kurokawa, K ^a   Suzuki, T ^a   Yamanaka, H ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PROGNOSIS; SEMINOMA; TESTIS TUMOR;

EID: 0032414119     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02550551     Document Type: Article

References (23)

1. Richie, J. P.: Neoplasms of the testis. In: Walsh, P. C., Retik, A. B., Stamey, T. A., Vaughan, E. P. Jr. (eds): Campbell's Urology. W. B. Saunders Co., Philadelphia 1992, pp. 1222-1255.
2. Zagars, G. K.: Management of stage I seminoma: Radiotherapy. In: Horwich, A. (ed.): Testicular Cancer. Williams & Wilkins, Baltimore 1991, pp. 83-107.
3. Einhorn, L. H, Donohue, J. D.: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann. Intern. Med., 87, 293 (1977).
4. Pizzocaro, G., Piva, L., Salvioni, R., Zanoni, F., Milani, A.: Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer. Cancer, 50, 2411 (1985).
5. Suzuki, K., Matsumoto, K., Hashimoto, K, Kurokawa, K., Jinbo, S., Suzuki, T., Imai, K., Yamanaka, H., Kawashima, K., Takahashi, H Carboplatin-based combination chemotherapy for testicular cancer: Relationship among administration dose of carboplatin, renal function and myelosuppression. Acta Urol. Jpn., 41, 775 (1995).
6. Norgaard-Pedersen, B., Schultz, H. P., Arends, K.: Tumor marker in testicular germ cell tumors. Five-year experience from the DATECA study 1976-1980 Acta Radiol. Oncol., 23, 287 (1984).
7. Mirimanoff, R. O., Shipley, W. U., Dosoretz, D. E., Meyer, J. E.: Pure seminoma of the testis: The results of radiation therapy in patients with elevated human chorionic gonadotropin titers. J. Urol., 134, 1124 (1985).
8. Ellenbroek, N. A., Tran, L. M., Selch, M. T., Taylor, J. M G., Parker, R. G.: Testicular seminoma A study of 103 cases treated at UCLA. Amer. J. Clin. Oncol., 11, 93 (1988).
9. Suzuki, K., Ozawa, M., Nakazato, H., Kurokawa, K., Hayashi, M., Jinbo, S., Kobayashi, M., Suzuki, T., Imai, K., Yamanaka, H.: Clinical study on 78 cases of testicular tumor (in Japanese). Acta Urol. Jpn., 41, 97 (1995).
10. Fossa, S. D, Aass, N., Kaalhus, A: Radiotherapy for testicular seminoma stage I: Treatment results and long term post-irradiation morbidity in 365 patients. Int. J. Radiat. Oncol. Biol. Phys., 16, 383 (1989).
11. Schwartz, B., Auman, R., Peretsman, S. J., Moul, J. W., Deshon, G. E., Hernandez, J., Rozanski, T. A, Thrasher, J. B.: Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis. J. Surg. Oncol., 61, 131 (1996).
12. Meier, J. G., Sulak, M. H.: Radiation therapy in malignant testis tumors. Cancer, 32, 1217 (1983).
13. Javadpour, N., McIntire, K. R., Waldmann, T. A.: Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma. Cancer, 42, 278 (1978).
14. Swartz, D. A., Johnson, E. D., Hussey, D. H.: Should an elevated human chorionic gonadotropin titer alter therapy for seminoma? J. Urol., 131, 63 (1984).
15. Kurman, R. J, Peter, T. S., Robert, K. M., Thomas, A. W., Nassar, J.: Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using indirect immunoperoxidase technique. Cancer, 40, 2136 (1977).
16. Morinaga, S., Ojima, M., Sasano, N.: Human chorionic gonadotropin and alpha-fetoprotein in testicular germ cell tumors. An immunohistochemical study in comparison with tissue concentrations. Cancer, 52, 1281 (1983).
17. Bellet, D. H., Ozturk, M., Bidart, J. M., Bohuun, C. J., Wands, J. R.: Sensitive and specific assay for human chorionic gonadotropin (hCG) based on anti-peptide and anti-hCG monoclonal antibodies: Construction and clinical implications. J. Clin. Endocrinol. Metab., 63, 319 (1986).
18. Mirimanoff, R. O, Sinzing, M., Kruger, M.: Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 27, 17 (1993)
19. Mumperow, E., Hartmann, M.: Spermatic cord β-Human chorionic gonadotropin levels in seminoma and their clinical implications. J. Urol., 147, 1041 (1992).
20. Sugawara, T.: Clinical study of testicular tumor: Tumor tissue content of HCG in seminoma (in Japanese). Jpn. J. Urol., 80, 847 (1989).
21. Peckham, M. J., Hamilton, C. R., Horwich, A.: Surveillance after orchiectomy for stage I seminoma of the testis. Br. J. Urol., 59, 343 (1987).
22. Allhoff, E. P., Kiedke, S., Riese, W. D., Stief, C., Schneider, B: Stage I seminoma of the testis. Adjuvant radiotherapy or surveillance? Br. J. Urol., 68, 190 (1991).
23. Duchesne, G. M., Horwich, A., Dearnaley, D. P., Nicholls, J., Peckham, M. J., Hendry, W. F.: Orchidectomy alone for stage I seminoma of the testis. Cancer, 65, 1115 (1990).